Clinical Trials Browser

Phase 1 × Imiquimod × 90 days × Clear all

NCT01795313 2026-02-05

Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

Phase 1 Terminated

Ependymoma

NCT02600949 2026-01-29

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms